Fintech
Fintech Company Albo Aims for Cash Network for Its Users
Mexican fintech company Albo partnered with PayCash to expand its cash deposit network across 20,000 locations in Mexico, including supermarkets, pharmacies, and convenience stores. This allows Albo users to deposit up to 20,000 pesos easily. Albo’s CEO, Ángel Sahagún, emphasized the aim to simplify cash deposits. In 2023, Albo raised $40 million in Series C funding.
Mexican fintech company Albo announced a partnership with Mexican platform PayCash to increase its network for cash deposits. According to the financial company, this system reaches more than 20,000 establishments with different chains throughout Mexico through which its clients can deposit cash into their accounts.
According to a statement, the fintech company Albo will add PayCash as a commission agent and through this alliance users will be able to deposit up to a maximum of 20,000 pesos in businesses such as supermarket chains, pharmacies and convenience stores.
“Our main goal is to make everything much simpler when it comes to Albo, and giving them more and new options so they can deposit cash in a matter of minutes is part of that promise,” said the fintech company’s CEO, Ángel Sahagún, in a statement from the firm.
To complement this new alliance, the Electronic Payment Fund Institution (IFPE) added a new update to the application, which will allow its users to locate the nearest establishments.
Albo currently maintains alliances with specialized payment platforms such as Dapp and PESPay
“We want a customer who wants to deposit cash into their Albo account to only need to walk a few steps and have multiple options to do so, without friction, long distances or wasting time,” said Sahagún.
In addition to PayCash, Albo currently maintains alliances with specialized payment platforms such as Dapp and PESPay. In addition, in 2023, the fintech acquired Delt.ai, focused on financing for the business sector, with which it sought to enter into business financing and boost its business verticals.
In September 2023, Albo raised $40 million in investment in its Series C, which was intended to strengthen its offering anchored in the services of its IFPE license, an authorization it obtained in May 2022 in accordance with the Fintech Law.
With this investment, the firm claimed at the time that it was close to profitability and that the key would be found in the service offered by the platform. According to its records, a person who uses IFPE’s services, 12 months later, leaves five times more income than in their first month of use.
__
(Featured image by Clay Banks via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in EL ECONOMISTA. A third-party contributor translated and adapted the article from tthe original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Fintech2 weeks ago
Fintech Company Satispay Raises 60 Million Euros Led by Addition
-
Biotech3 days ago
ATB Therapeutics Raises €54 Million and Attracts a Pharmaceutical Giant
-
Fintech1 week ago
LAKPA Strengthens Its Offering in Mexico with Model Portfolios from JP Morgan AM
-
Biotech1 day ago
21 Invest Launches the First Fund Dedicated to the Healthcare Sector, with a Closing of 70 Million and a Target of 150 Million